Immunology of scorpion toxins and perspectives for generation of anti-venom vaccines.
Scorpions and other venomous animals contain concentrates of biologically active substances developed to block vital physiological and biochemical functions of the victims. These have contrasting human health concerns, provide important pharmacological raw material and pose a serious threat to human life and health in tropical and subtropical regions. Because only occasional and minor quantities of venom are introduced into the human organism with a scorpion sting and their mortal effect is an acute phenomenon these substances are unknown to the immune defense system and thus no immunity has appeared against them during evolution. Antidotes prepared from animal anti-sera are effective against some species of scorpions but depend on the manufacturer and the availability of product to the medical community. Although significant progress has been made in immunological studies of certain groups of toxins, few centers are dedicated to this research. Information is still insufficient to generate a comprehensive picture of the subject and to propose vaccines against venoms. A novel approach based on mimotopes selected from phage-displayed random peptide libraries show potential to impel further progress of toxin immunological studies and to provide putative vaccine resources. In this report we revise the "state of the art" in the field.
Gazarian
Karlen G
KG
Department of Molecular Biology and Biotechnology of Institute of Biomedical Research, Mexican National University (UNAM), Ciudad Universitaria, Circuito escolar s/n, Ciudad Universitaria, 04510 México DF, México. karlen@servidor.unam.mx
Gazarian
Tatiana
T
Hernández
Ricardo
R
Possani
Lourival D
LD
D000818:Animals; D000939:Epitopes / Q000737:chemistry / Q000276:immunology*; D012604:Scorpion Venoms / Q000737:chemistry / Q000276:immunology*; D012605:Scorpions / Q000737:chemistry*; D014612:Vaccines / Q000276:immunology*
D000939:Epitopes; D012604:Scorpion Venoms; D014612:Vaccines